Advanced-glycation end-products axis: A contributor to the risk of severe illness from COVID-19 in diabetes patients

Compelling pieces of evidence derived from both clinical and experimental research has demonstrated the crucial role of the receptor for advanced-glycation end-products (RAGE) in orchestrating a plethora of proinflammatory cellular responses leading to many of the complications and end-organ damages...

Descripción completa

Detalles Bibliográficos
Autores principales: Rojas, Armando, Lindner, Cristian, Gonzàlez, Ileana, Morales, Miguel Angel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107984/
https://www.ncbi.nlm.nih.gov/pubmed/33995847
http://dx.doi.org/10.4239/wjd.v12.i5.590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107984/
https://www.ncbi.nlm.nih.gov/pubmed/33995847
http://dx.doi.org/10.4239/wjd.v12.i5.590

Ejemplares similares